SHINE is excited to join other nuclear medicine leaders from around the world at EANM ’22 from Oct. 15-19 in Barcelona.
The 35th Annual Congress of the European Association of Nuclear Medicine will be a great place to catch up on all the latest in diagnostic imaging and therapeutics.
We’ll be in Booth #63 and would love to tell you about our plans to be the industry leader in fusion-driven medicine, including:
- The world’s largest medical isotope production facility, which will initially focus on molybdenum-99 and is scheduled to get its operating license from the NRC next year.
- Our current small-scale production of lutetium-177. We submitted a drug master file to the U.S. Food and Drug Administration earlier this year.
- Our plan to be the only fully vertically integrated manufacturer of Lu-177.
- How our fusion process will be safer and cleaner than fission-based methods while providing a stable U.S.-based supply source of critical isotopes.
Will we see you in Barcelona? Stop by our booth, or contact us here.